The molecular analysis of tumors, such as melanoma, has benefited significantly from microarray technology that can facilitate the classification of tumors based on the differential expression of genes. The data summarized in this review describe the molecular profile of aggressive cutaneous and uveal melanoma cells as that of multiple phenotypes similar to a pluripotent, embryonic-like stem cell. A noteworthy example of the plasticity of the aggressive melanoma cell phenotype is demonstrated by the ability of these tumor cells to engage in vasculogenic mimicry and neovascularization. A review of the current evidence demonstrating important cellular and molecular determinants of melanoma vasculogenic mimicry is presented. In addition, novel signaling pathways are discussed, involving VE-cadherin, EphA2, FAK, and PI 3-kinase, which promote cell migration, invasion, and matrix remodeling. The observations summarized in this review describe some of the key molecular events that regulate the process of melanoma vasculogenic mimicry and identify new signal transduction pathways that can serve as putative targets for therapeutic intervention.
Expression of multiple molecular phenotypes
The classification of cancers, such as melanoma, has benefited significantly from molecular profiling studies (Bittner et al., 2000; Liotta and Petricoin, 2000; Khan et al., 2001) . Gene-expression profiling allows a simultaneous analysis of multiple markers that can be used to diagnose tumors, classify cancers into subgroups, and identify candidate targets for therapeutic exploitation (Khan et al., 1998 (Khan et al., , 2001 Alizadeh et al., 2000; Bittner et al., 2000) . Recent studies aimed at characterizing the molecular signature of melanoma tumor cells generated a classification scheme for malignant cutaneous melanoma (Bittner et al., 2000) , in addition to a molecular profile for uveal melanoma . Detailed microarray analyses of the respective genetic profiles are available at (http://www.nhgri.nih.gov/DIR/Microarray/Melanoma Supplement/index.html). These molecular tools demonstrated how global transcript analysis could contribute to the classification of melanoma, which may hold great promise in improving diagnosis and treatment.
Quite unexpectedly, the microarray analyses studies of differential gene expression of highly aggressive vs poorly aggressive human cutaneous and uveal melanoma cell lines (Bittner et al., 2000; Seftor et al., 2002) revealed the coexpression of multiple phenotype-specific genes by the aggressive tumor cells, including those of endothelial, epithelial, fibroblastic, hematopoietic, kidney, neuronal, muscle, and several precursor cell types. These genes, highlighted in Table 1 , suggested that aggressive melanoma cells may undergo a genetic reversion to a pluripotent, embryonic-like phenotype. However, the biological significance of the unexpected expression of multiple molecular phenotypes by melanoma cells remains enigmatic. Indeed, these findings have prompted further investigation regarding the potential relevance of a 'plastic' tumor cell phenotype, and challenge our current thinking of identifying and targeting tumor cells that may masquerade as other cell types.
Tumor cell plasticity underlies melanoma vasculogenic mimicry
Stem cell plasticity is a hotly debated topic that has ignited both the biomedical and lay communities. The literature is becoming saturated with reports on the stem cell plasticity of adult cells to differentiate (dedifferentiate or transdifferentiate) into surprisingly many cell types (D'Amour and Gage, 2002; Holden and Vogel, 2002; Vogel, 2002 , Weissman, 2000 . This type of research has challenged the use and need for human embryonic stem cells in a larger debate over ethics and biomedicine. However, recent reports are casting doubt on the plasticity of adult stem cells (Holden and Vogel, 2002; Vogel, 2002) , and caution the need for more rigorous scientific standards.
Many of the biological properties germane to embryogenesis, including stem cell plasticity, are also pertinent in tumor growth. For example, during embryonic development, the formation of primary vascular networks occurs by the process of vasculogenesis, the in situ differentiation of mesodermal progenitor cells (angioblasts or hemangioblasts) to endothelial cells that organize into a primitive network (for review, see Risau, 1997; Carmeliet, 2000) . The subsequent remodeling of the vasculogenic network into a more refined complex of vasculature occurs through angiogenesis, the growth of new capillaries from pre-existing networks. Similarly, it is widely accepted that during cancer progression, tumors require a blood supply for growth (Folkman, 1995; Rak and Kerbel, 1996; Kumar and Fidler, 1998) . Based on the molecular profile of aggressive melanoma cells (Table 1) , together with novel in vitro observations and correlative histopathology findings, our laboratory and collaborators have introduced the concept of vasculogenic mimicry (Figure 1 ) to describe the plasticity and unique ability of aggressive melanoma tumor cells to express endothelial-associated genes and form tubular structures and patterned networks in three-dimensional culture that mimic embryonic vasculogenic networks (Maniotis et al., 1999; Hendrix et al., 2001; Hess et al., 2001 . In animal and patient tumors, histological analysis has revealed the architecture of the aggressive tumors to consist of extravascular laminin-rich networks surrounding spheroids of tumor cells . Many of these networks are lined by tumor cells delineating channels containing red blood cells and plasma, and possibly providing a perfusion mechanism and dissemination route within the tumor compartment that functions either independent of or simultaneously with angiogenesis. Recent observations using intravenous tracers have confirmed the presence of a laminin-positive, fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma (Clarijs et al., 2002; Maniotis et al., 2002) , and may function in a lymphatic capacity (VEGF-C positive tumor cells; Table 1 ) as well. Tumors exhibiting vasculogenic mimicry have a poor prognosis (Maniotis et al., 1999; Warso et al., 2001) which underscores the clinical relevance of these new findings. The biological significance of vasculogenic mimicry has been uniquely demonstrated in an ischemic limb model, where human metastatic melanoma cells participated in the neovascularization of circulation-deficient muscle . This study provided new perspectives on tumor Selected genes with a differential expression of 2.5-fold or greater are reported as a ratio for highly aggressive C8161 compared to poorly aggressive C81-61 cutaneous melanoma cells, or highly aggressive MUM-2B compared to poorly aggressive MUM-2C uveal melanoma cells Figure 1 Experimental model for vasculogenic mimicry by aggressive melanoma cells highlighting the importance of VE-cadherin, EphA2, and laminin 5 g2, in the formation of patterned, vasculogenic-like networks in three-dimensional culture, which recapitulates the patterned networks seen in a histological section from a patient's aggressive melanoma tumor cell plasticity and challenged existing dogma regarding the fate and function of aggressive tumor cells in an ischemic microenvironment.
Role of vascular endothelial (VE)-cadherin, epithelial cell kinase (EphA2), and laminin 5 c2 chain in the vasculogenic phenotype
The molecular underpinnings of melanoma vasculogenic mimicry are beginning to unfold. Recent experimental evidence has shown the importance of several key molecules in the formation of vasculogenic-like networks by melanoma cells, including VE-cadherin (CD144 or cadherin 5), EphA2, and laminin Hess et al., 2001; Seftor et al., 2001) . These molecules (and their binding partners) are also essential in the formation and maintenance of blood vessels (Risau, 1997; Carmeliet, 2000) . VE-cadherin is an adhesive protein, previously considered to be endothelial cell-specific, belonging to the cadherin family of transmembrane proteins promoting homotypic cell-tocell interaction (Hynes, 1992; Kemler, 1992; Lampugnani et al., 1992; Gumbiner, 1996) . EphA2 is a receptor protein tyrosine kinase that is part of a large family of ephrin receptors (Pasquale, 1997) . Binding of EphA2 to its ligand ephrin-A1 results in the phosphorylation of EphA2; however, there is evidence indicating that EphA2 can also be constitutively phosphorylated in unstimulated cells (Rosenburg et al., 1997) . Strong expression of EphA2 and ephrin-A1 has been associated with increased melanoma thickness and decreased survival, and the EphA2/ephrin-A1 pathway has been linked to tumor cell proliferation (Straume and Akslen, 2001). Laminins are major components of basement membranes and play an active role in neurite outgrowth, tumor metastasis, cell attachment and migration, and angiogenesis (Malinda and Kleinman, 1996; Colognato and Yurchenco, 2000; Straume and Akslen, 2001) . Proteolytic cleavage of laminin, particularly the laminin 5 g2 chain, can alter and regulate the integrin-mediated migratory behavior of certain cells (Giannelli et al., 1997; Malinda et al., 1999; Koshikawa et al., 2000; Straume and Akslen, 2001) , illustrating its potential importance as a molecular trigger in the microenvironment.
The importance of VE-cadherin, EphA2, and laminin 5 g2 chain is highlighted in Table 1 , where microarray analyses revealed that these three molecules, among others, were dramatically overexpressed in aggressive human cutaneous and uveal melanoma cells (Bittner et al., 2000; Hendrix et al., 2001; Hess et al., 2001; Seftor et al., 2001 Seftor et al., , 2002 . At the protein level, these molecules were expressed only by aggressive tumor cells, and not by nonaggressive or poorly aggressive melanoma cells. The biological relevance of these molecules in vasculogenic mimicry was further demonstrated by downregulating their expression independently and measuring the consequences on their ability to form vasculogenic-like networks. This approach revealed that downregulation of VE-cadherin, EphA2, or laminin 5 g2 chain resulted in the complete inability of aggressive melanoma cells to engage in the formation of vasculogenic-like networks in three-dimensional culture Hess et al., 2001; Seftor et al., 2001) . Additional experiments focused on tumor cellassociated extracellular matrix led to the discovery of the inductive potential of the microenvironment preconditioned by aggressive melanoma cells and shown to influence poorly aggressive melanoma cells to assume a vasculogenic phenotype . These data, along with subsequent observations of vascular cellassociated gene expression, suggest that highly aggressive melanoma cells deposit molecular signals in their environment that have the potential to induce a vasculogenic phenotype in poorly aggressive cells, with respect to the formation of vasculogenic-like networks and the concomitant expression of vascular-associated genes (VE-cadherin, EphA2, and laminin 5 g2 chain).
Novel signaling pathways for therapeutic exploitation
The identification of EphA2 as an important tyrosine kinase mediating the process of vasculogenic mimicry prompted us to explore the mechanisms by which its expression and function are regulated in the highly aggressive melanoma cells. Utilizing immunocytochemistry techniques, we found that the EphA2 and VEcadherin colocalized to areas of cell-cell adhesion; additionally, using coimmunoprecipitation an interaction occurred between these two molecules. With antisense oligonucleotide technology, evidence was generated to suggest that VE-cadherin expression regulated the expression of EphA2 at the membrane in addition to its phosphorylation status . Based on these data, we proposed that VE-cadherin mediated the localization of EphA2 at the membrane where it could engage its membrane-bound ligand and become phosphorylated on tyrosines. In addition, phosphorylation of EphA2 may facilitate the phosphorylation of VE-cadherin, resulting in a loosening of cellcell adhesion and allowing for an increase in cell migration, invasion, and vasculogenic mimicry.
After establishing the mechanism by which the expression and function of EphA2 was regulated in highly aggressive melanoma cells, we investigated the signaling pathways activated downstream of EphA2. Using a series of coimmunoprecipitation experiments and antisense oligonucleotide strategies, EphA2 was found to interact with focal adhesion kinase (FAK) and was able to regulate FAK activity during the process of vasculogenic mimicry in vitro. Furthermore, an important role was discovered for PI3K in vasculogenic mimicry (Hess, 2002) .
Another potential downstream effector of both EphA2 and VE-cadherin is phosphoinositide 3-Kinase (PI3K). PI3K is a lipid kinase consisting of a regulatory subunit, p85, and a catalytic subunit, p110. Once activated, PI3K phosphorylates phosphoinositide-4,5-bisphosphate (PIP2) to form phosphoinositide-3,4,5-trisphosphate (PIP3), which regulates a variety of cellular functions. PI3K activity has been implicated in the recruitment of a variety of cell signaling components to the plasma membrane where they can induce cell motility, survival, and tubulogenesis (Bazzoni et al., 1999) . PI3K activity has also been found to be important for both endothelial cell sprouting (Kim et al., 2000) and formation of tubules by kidney epithelial cells (Khwaja et al., 1996) . Our initial studies suggested that PI3K plays an important role in vasculogenic mimicry. Based on other reports indicating that PI3K is downstream of EphA2 (Pandey et al., 1994) and VE-cadherin (Carmeliet et al., 1999) , we have placed PI3K as a potential downstream effector of EphA2 and VE-cadherin. Recent evidence that supports our hypothesis has indicated PI3K activity to be linked with that of protein kinases and small GTPases such as Rac1 and Cdc42 (Chan et al., 2002) . Chan et al. provided evidence that suggests that tyrosine phosphorylation of the p85 subunit of PI3K by protein kinases (either cytoplasmic or membrane receptors) causes a conformational change in the protein. This change results in a neutralization of the inhibitory domain with the p85 subunit allowing PI3K to become activated in response to signals transduced from Rac1 or Cdc42 (Chan et al., 2002) . These data, coupled with our findings, suggest that PI3K could act downstream of EphA2 and VE-cadherin in conjunction with Rac1 and Cdc42 in highly aggressive melanoma cells, thus resulting in the formation of vasculogenic-like networks.
An investigation of other signaling molecules that regulate cell migration and invasion revealed that the small GTPases, Rac1 and Cdc42, had an increased Figure 2 A hypothetical model for signaling during melanoma vasculogenic mimicry involving the cooperative interactions of VEcadherin and EphA2, facilitating downstream signaling with phosphoinositide 3-kinase (PI3K) and focal adhesion kinase (FAK), initiated by the ephrin-A1 ligand binding. In this model, VE-cadherin is shown to mediate the engagement of ligand by EphA2 and result in EphA2 phosphorylation and the subsequent conversion of Rac1 and Cdc42 to their GTP-bound active states. Activation of Rac1 and Cdc42 would then promote the formation of lamellipodia and filopodia, and recruit FAK to the newly formed focal adhesions. At the membrane, FAK could then serve as a bridging protein between EphA2 and possibly integrins to facilitate the potential phosphorylation of paxillin at the focal adhesion sites. The increase in cell migration associated with phosphorylation of FAK and paxillin, as well as the increase in MMP-2 production resulting from PI3K activation could play significant roles in the vasculogenic mimicry process activation in highly aggressive melanoma cells compared with poorly aggressive melanoma cells. Interestingly, Cdc42 and Rac1 have been shown to be required for capillary lumen formation by endothelial cells cultured on a three-dimensional matrix (Bayless and Davis, 2002) . Bayless and Davis (2002) provided evidence that inhibition of Cdc42 and Rac1 activity by expressing dominant-negative forms of these proteins in endothelial cells blocked vacuole formation and subsequently lumen formation, suggesting that the activity of these two molecules is important for these processes. We have found an increase of Cdc42 and Rac1 activity in highly aggressive melanoma cells during the formation of tubular networks and therefore suggest that the role of Cdc42 and Rac1 may be twofold. It may help to promote cell migration and facilitate the formation of lumens. Throughout our studies of melanoma vasculogenic mimicry, we have found that tubular networks begin to form 3-4 days after plating the tumor cells on three-dimensional matrices, and progress in complexity as the cells are maintained in culture (Maniotis et al., 1999; Folberg et al., 2000; Hess et al., 2001) . On crosssectional analysis of 6-day cultures we find lumens beginning to form, although they still contain extracellular matrix. The formation of lumens in the tubular structures corresponds with the increase of Cdc42 and Rac1 activity observed around day 6, suggesting that these two GTPases play a role in lumen formation of the tubular networks.
Collectively, the data generated to date suggest that EphA2, whose expression and function is regulated by VE-cadherin, activates several key signaling pathways involving FAK and PI3K, which help to promote cell migration, invasion, and matrix remodeling, resulting in the formation of vasculogenic-like networks by aggressive melanoma cells. Figure 2 presents a possible scenario of potential signal transduction pathways important for the process of melanoma vasculogenic mimicry. In this model, homotypic binding of VEcadherin molecules on adjacent cells results in the localization of EphA2 to the membrane where it can engage its membrane-bound ligand, ephrin-A1, resulting in phosphorylation. Phosphorylation of EphA2 results in the conversion of Rac1 and Cdc42 from their GDPbound inactive forms to their GTP-bound active forms via an unknown mechanism. This conversion promotes the formation of lamellipodia and filopodia, and the recruitment of FAK to newly forming focal adhesions. Once at the membrane, FAK is able to interact with both EphA2 and possibly the integrins, resulting in its phosphorylation and activation, which in turn activates paxillin, thus increasing focal adhesion turnover and cell migration. Furthermore, the activation of PI3K may increase the levels of MMP-2 production, thus promoting the formation of vasculogenic-like networks. The expression of EphA2 and VE-cadherin by aggressive melanoma cells, the downstream signaling pathways that they activate, and the important role they play in the formation of vasculogenic-like networks by highly aggressive melanoma cells supports the concept of melanoma tumor cell plasticity. These highly aggressive melanoma cells have adopted endothelial-like properties through an apparent transdifferentiation process, facilitating the formation of vascular structures both in vitro and in vivo, which may serve as an additional means for tumor perfusion and ultimately tumor metastasis. The observations summarized in this review describe some of the key molecular events that regulate the process of melanoma vasculogenic mimicry and identify new signal transduction pathways that can serve as putative targets for therapeutic intervention.
